Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabel Sánchez-Ortega

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Mycoses|March 31, 2016
Invasive fungal infections in AML/MDS patients treated with azacitidine: a risk worth considering antifungal prophylaxis?Helena Pomares, Montserrat Arnan, Isabel Sánchez-Ortega, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 10, 2011
Dasatinib as salvage therapy for steroid refractory and imatinib resistant or intolerant sclerotic chronic graft-versus-host diseaseIsabel Sánchez-Ortega, Octavio Servitje, Montserrat Arnan, et al.
Croatian Medical Journal|July 5, 2016
Imatinib and dasatinib as salvage therapy for sclerotic chronic graft-vs-host diseaseIsabel Sánchez-Ortega, Rocío Parody, Octavio Servitje, et al.
Journal of Medical Economics|April 2, 2013
Cost-effectiveness of primary antifungal prophylaxis with posaconazole versus itraconazole in allogeneic hematopoietic stem cell transplantationIsabel Sánchez-Ortega, Beatriz Patiño, Carmen Muñoz, et al.
Revista Iberoamericana De Micologia|November 24, 2011
[Invasive aspergillosis with extrapulmonary involvement: pathogenesis, clinical characteristics and prognosis]Luis Eduardo López-Cortés, Carolina Garcia-Vidal, Josefina Ayats, et al.
Antimicrobial Agents and Chemotherapy|October 3, 2012
Effect of posaconazole on cyclosporine blood levels and dose adjustment in allogeneic blood and marrow transplant recipientsIsabel Sánchez-Ortega, Lourdes Vázquez, Carmen Montes, et al.
Hemasphere|May 1, 2023
An International Survey on Grading, Diagnosis, and Management of Immune Effector Cell-Associated Hematotoxicity (ICAHT) Following CAR T-cell Therapy on Behalf of the EBMT and EHAKai Rejeski, Raffaella Greco, Francesco Onida, et al.
Statistical Methods in Medical Research|March 8, 2022
Benchmarking survival outcomes: A funnel plot for survival dataHein Putter, Dirk-Jan Eikema, Liesbeth C de Wreede, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 29, 2014
Serum galactomannan-based early detection of invasive aspergillosis in hematology patients receiving effective antimold prophylaxisRafael F Duarte, Isabel Sánchez-Ortega, Isabel Cuesta, et al.
The Lancet. Haematology|May 25, 2024
Donor lymphocyte infusion after allogeneic haematopoietic cell transplantation for haematological malignancies: basic considerations and best practice recommendations from the EBMTSimona Pagliuca, Christoph Schmid, Nicole Santoro, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Mycoses|March 31, 2016
Invasive fungal infections in AML/MDS patients treated with azacitidine: a risk worth considering antifungal prophylaxis?Helena Pomares, Montserrat Arnan, Isabel Sánchez-Ortega, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 10, 2011
Dasatinib as salvage therapy for steroid refractory and imatinib resistant or intolerant sclerotic chronic graft-versus-host diseaseIsabel Sánchez-Ortega, Octavio Servitje, Montserrat Arnan, et al.
Croatian Medical Journal|July 5, 2016
Imatinib and dasatinib as salvage therapy for sclerotic chronic graft-vs-host diseaseIsabel Sánchez-Ortega, Rocío Parody, Octavio Servitje, et al.
Journal of Medical Economics|April 2, 2013
Cost-effectiveness of primary antifungal prophylaxis with posaconazole versus itraconazole in allogeneic hematopoietic stem cell transplantationIsabel Sánchez-Ortega, Beatriz Patiño, Carmen Muñoz, et al.
Revista Iberoamericana De Micologia|November 24, 2011
[Invasive aspergillosis with extrapulmonary involvement: pathogenesis, clinical characteristics and prognosis]Luis Eduardo López-Cortés, Carolina Garcia-Vidal, Josefina Ayats, et al.
Antimicrobial Agents and Chemotherapy|October 3, 2012
Effect of posaconazole on cyclosporine blood levels and dose adjustment in allogeneic blood and marrow transplant recipientsIsabel Sánchez-Ortega, Lourdes Vázquez, Carmen Montes, et al.
Hemasphere|May 1, 2023
An International Survey on Grading, Diagnosis, and Management of Immune Effector Cell-Associated Hematotoxicity (ICAHT) Following CAR T-cell Therapy on Behalf of the EBMT and EHAKai Rejeski, Raffaella Greco, Francesco Onida, et al.
Statistical Methods in Medical Research|March 8, 2022
Benchmarking survival outcomes: A funnel plot for survival dataHein Putter, Dirk-Jan Eikema, Liesbeth C de Wreede, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 29, 2014
Serum galactomannan-based early detection of invasive aspergillosis in hematology patients receiving effective antimold prophylaxisRafael F Duarte, Isabel Sánchez-Ortega, Isabel Cuesta, et al.
The Lancet. Haematology|May 25, 2024
Donor lymphocyte infusion after allogeneic haematopoietic cell transplantation for haematological malignancies: basic considerations and best practice recommendations from the EBMTSimona Pagliuca, Christoph Schmid, Nicole Santoro, et al.
Pageof 5